Femtech startups raised over $120M in July π₯
Here's a quick roundup of the femtech startups that raised money last month.
If you're tracking who's writing checks into this space, our VC Funds Database tracks the funds actively investing in femtech and women's health right now, including check size, stage, and thesis, updated weekly.
Funding Rounds in Femtech for July 2026β
βοΈ Rejoni raised $25M to prepare its uterine healing hydrogel for FDA approval and launch.
β Founded by: Amar Sawhney, PhD
β About: Advance the Juveena Hydrogel System, a temporary spacer designed to prevent intrauterine adhesions after transcervical gynecological procedures, toward FDA approval and commercial launch.
β
βοΈ Corner Health secured $32.5M in Seed and Series A funding for nurse practitioner-owned primary care practices.
β Founded by: Lava Sunder and Anne Gifford
β About: Help nurse practitioners open and run their own independent primary care practices, rebuilding access to care outside the traditional clinic model.
β
βοΈ Anodyne Nanotech raised $12.6M Series A to advance its once-weekly GLP-1 patch into Phase 1.
β Founded by: Jake Lombardo, Hojatollah Rezaei Nejad, and Konstantinos Tzortzakis
β About: Advance ANN-101, a needle-free microneedle patch delivering GLP-1 therapy, into Phase 1 clinical trials, with the goal of reducing the side effects that drive high discontinuation rates on injectable GLP-1s.
β
βοΈ ApothΓ©kary raised $16M to scale its herbal tincture brand.
β Founded by: Shizu Okusa
β About: Scale its herbal tincture line, positioned as a replacement for daily habits like caffeine and alcohol, with fresh capital split between venture funding and debt financing.
β
βοΈ SONATA launched a doctor-led preventative health membership with $7M in funding.
β Founded by: Dr. Sagan Schultz and David Deng
β About: Combine whole-genome sequencing, 140+ blood biomarkers, and clinical AI with a physician-led care team, including cycle-phase-aware hormone testing for women's health.
β
βοΈ DITTO secured $6M to expand its menstrual health research platform.
β Founded by: Alice van der Schoot and Adam Kugler
β About: Expand its evidence-based supplement line and clinical research program, including studies into the link between PMDD and ADHD.
β
βοΈ Materna Medical raised $5M to launch its device designed to protect the pelvic floor during vaginal delivery.
β Led by: Tracy MacNeal, President & CEO
β About: Advance Materna Prep, a device designed to pre-stretch the pelvic floor during labor and reduce childbirth-related pelvic floor injuries.
β
βοΈ Juno Bio raised $3.8M to open a CLIA-certified sequencing lab for women's health.
β Founded by: Hana Janebdar
β About: Open a purpose-built sequencing laboratory in Oakland, California, to scale precision vaginal microbiome testing and multi-omics for women's health.
β
βοΈ Imagion Biosystems raised AU$3.75M, extending its Siemens partnership to advance a breast cancer trial.
β Led by: Dr. Isaac Bright, CEO
β About: Fund the launch of a Phase 2 clinical trial for its MagSense HER2 imaging agent, following FDA clearance of the IND application.
β
βοΈ Mila raised $2.5M pre-seed to build a design-led intimate wellness brand.
β Founded by: Kim Aviv and Ada Trujillo
β About: Build out its portfolio of beauty-inspired intimate wellness products, including its Aura device and Bloom gliding mist, and pursue mass retail partnerships.
β
βοΈ Estrigenix Therapeutics raised $2M to advance its selective estrogen therapy.
β Founded by: Dr. Karyn Frick, Dr. Bill Donaldson, and Dr. Dan Sem
β About: Advance its selective estrogen receptor beta (ERΞ²) platform through translational preclinical development, targeting the cognitive and mood effects of menopause without the cancer and cardiovascular risks of traditional hormone therapy.
β
βοΈ KΔhu SiliconBio secured Β£1.2M to advance continuous hormone monitoring.
β Founded by: Dr. James Flewellen and Prof. Teuta Pilizota
β About: Develop a biosensor combining engineered bacteria and silicon chip technology to continuously track hormone levels throughout the day, supporting research into conditions like endometriosis and PCOS.
β
βοΈ Chiron raised a Β£900K seed for its AI platform supporting patients between clinic visits, with plans for a women's health expansion.
β Founded by: Carron Manning
β About: Scale its AI-driven platform that turns episodic clinical care into a continuous feedback loop, with expansion planned into women's health alongside its existing chronic pain and cardiometabolic work.
β
βοΈ Intu Diagnostics raised β¬1.1M for a lab-free, electricity-free HPV test.
β Founded by: Dr. Skaiste Arbaciauskaite and Dr. Dirk Kuhlmeier
β About: Fund IP protection and pilot manufacturing for its all-in-one diagnostic cartridge, which delivers PCR-quality HPV detection with no lab, electricity, or trained staff required.
β
βοΈ Muun Health secured a β¬700K grant to advance its wearable hormone monitoring patch.
β Founded by: Kerli Luks
β About: Advance development of a wearable device for continuous female hormone monitoring, backed by an Enterprise Estonia grant.
β
βοΈ Elle, MD raised C$1.1M to advance its non-hormonal birth control ring.
β Founded by: Dr. Jennifer Johnston
β About: Advance the Livv ring, a copper-based, non-hormonal contraceptive alternative to the pill and IUD, designed to reduce side effects like weight gain, nausea, and mood shifts.
β
βοΈ Avni Wellness, an Indian women's health startup, raised a $470K seed round.
β Founded by: Sujata Pawar
β About: Scale its toxin-free wellness brand for women's health across the Indian market.
β
Other Notable Moves in Women's Health
Not every headline this month was a startup raise. Two larger moves are also worth tracking if you're watching where capital is flowing in women's health more broadly:
Roche's Genentech signed a $490M breast cancer drug discovery deal with Astex Pharmaceuticals, a sign that big pharma is still actively shopping for oncology partnerships in the space.
TD Bank Group donated $1M to advance menopause brain health research, adding to a small but growing wave of corporate philanthropy targeting menopause-specific science.
β
July 2026 Femtech Funding, By the Numbers
- βTotal disclosed funding: $120M+ across 17 startup rounds
β - βLargest round: Rejoni's $25M raise for its uterine healing hydrogel
ββ - Most active category: Diagnostics and monitoring (Intu Diagnostics, Muun Health, KΔhu SiliconBio, Juno Bio, Imagion Biosystems)
- Geographic spread: Deals closed across the US, UK, Germany, Estonia, Canada, and India
β - Smallest disclosed round: Avni Wellness's $470K seed
β
Frequently Asked Questions About Femtech
What is femtech?β
Femtech (female technology) refers to software, diagnostics, products, and services that use technology to improve women's health and wellness. This includes solutions for reproductive health, pregnancy, menopause, menstrual health, pelvic and sexual health, and general wellness tailored specifically for women.
Why is femtech growing so rapidly?β
The femtech market is experiencing explosive growth due to several factors: increased awareness of women's health gaps in traditional healthcare, more women in decision-making roles at VC firms, technological advancements in AI and diagnostics, and a market opportunity estimated to reach over $60 billion by 2030. Historically, women's health has been underfunded and underserved, creating massive opportunities for innovation.
What types of investors fund femtech startups?β
Femtech startups are funded by a mix of traditional venture capital firms, impact investors, corporate venture arms from healthcare and pharma companies, angel investors (often with healthcare or women's health expertise), and increasingly, female-led VC funds specifically focused on women's health innovation. You can browse many of these funds, along with their check sizes and investment theses, in our VC Funds Database.
Which femtech sectors are attracting the most investment?β
In July 2026, hormone monitoring and diagnostics stood out as a particularly active category, with multiple startups (Intu Diagnostics, Muun Health, KΔhu SiliconBio, Juno Bio) raising capital for testing and monitoring technology. Reproductive health, pelvic health, and menopause care also continued to draw strong investor interest.
Is femtech only for women founders?β
No. While many femtech companies are founded or co-founded by women, some successful femtech companies have male or mixed-gender founding teams, including several in this month's roundup. What matters most is a deep understanding of the problem being solved and commitment to addressing real gaps in women's healthcare.
How can I track femtech funding and trends?β
Subscribe to specialized newsletters and databases like EverythingStartups that provide monthly roundups of femtech funding, follow femtech-focused VCs on LinkedIn, check our VC Funds Database for active investors in the space, and join femtech communities and networks for industry insights.
β
β
.png)
.png)
